Senna Plus is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Docusate Sodium; Sennosides.
Product ID | 71335-1181_5f3b3624-f7a7-4cdf-8c23-d1bdea9b8038 |
NDC | 71335-1181 |
Product Type | Human Otc Drug |
Proprietary Name | Senna Plus |
Generic Name | Sennosides And Docusate Sodium |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2000-01-01 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Labeler Name | Bryant Ranch Prepack |
Substance Name | DOCUSATE SODIUM; SENNOSIDES |
Active Ingredient Strength | 50 mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-04-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-04-12 |
Ingredient | Strength |
---|---|
SENNOSIDES | 8.6 mg/1 |
SPL SET ID: | 5f3b3624-f7a7-4cdf-8c23-d1bdea9b8038 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0615-5533 | Senna Plus | Sennosides and Docusate Sodium |
0904-6339 | Senna Plus | standardized senna concentrate and docusate sodium |
21695-722 | Senna Plus | Senna Plus |
45865-938 | Senna Plus | DOCUSATE SODIUM,SENNOSIDES |
46122-343 | Senna Plus | DOCUSATE SODIUM, SENNOSIDES |
46122-578 | Senna Plus | DOCUSATE SODIUM, SENNOSIDES |
46122-625 | Senna Plus | Docusate Sodium, Sennosides |
49999-711 | Senna Plus | Senna Plus |
55154-5889 | Senna Plus | standardized senna concentrate and docusate sodium |
57896-455 | Senna Plus | Sennosides and Docusate Sodium |
57896-458 | Senna Plus | Sennosides and Docusate Sodium |
59779-162 | Senna Plus | docusate sodium and sennosides |
59779-575 | Senna plus | DOCUSATE SODIUM, SENNOSIDES |
61919-684 | SENNA PLUS | SENNA PLUS |
61919-855 | SENNA PLUS | SENNA PLUS |
70000-0445 | Senna Plus | Senna Plus |
70518-1590 | Senna Plus | Senna Plus |
71335-0977 | Senna Plus | Senna Plus |
66424-378 | Senna Plus | Senna Plus |
71335-1181 | Senna Plus | Senna Plus |
70000-0520 | Senna Plus | Senna Plus |
70518-2462 | Senna Plus | Senna Plus |
69842-883 | Senna Plus | Senna Plus |
80136-455 | Senna Plus | Senna Plus |
53329-989 | Senna S | sennosides and docusate sodium |
57896-555 | SENNA-PLUS | Sennosides and Docusate Sodium |
49348-156 | SENNA-S | Sennosides and Docusate Sodium |
61715-019 | Senna-S | Sennosides and Docusate Sodium |
62011-0290 | SENNA-S | Sennosides and Docusate Sodium |
62011-0364 | Senna-S | Sennosides and Docusate Sodium |
49483-097 | SENNOSIDES AND DOCUSATE SODIUM | SENNOSIDES AND DOCUSATE SODIUM |
60687-622 | Sennosides and Docusate Sodium | Sennosides and Docusate Sodium |
63739-432 | Sennosides and Docusate Sodium | Sennosides and Docusate Sodium |